Abstract
This study aimed to investigate the impact of organic gallium (OG) on osteoporotic fracture healing in ovariectomized female Sprague-Dawley rats, as well as study the mechanisms of OG on osteoporotic fracture healing. Forty-five female Sprague-Dawley rats were divided into three groups: sham operation group (Sxas control group), ovariectomized group (Ovx), and Ovx treated with OG group (Ovx + OG). Rat femoral fractures were studied using a standardized fracture-healing model utilizing bone fixation with an intramedullary pin. Six weeks later, analyses of micro-CT, histomorphometric, RNA extraction, RT-qPCR, and serum were performed following sacrifice of all mice. In comparison with Ovx group, OG can significantly increase bone volume (BV), tissue volume (TV), BV/TV radio, bone strength, callus bony area, and as similar to BMP-2 expression. OG treatment elevated OPG messenger RNA (mRNA) and inhibited RANKL mRNA, and showed an effect on OPG/RANKL ratio. OG treatment can inhibit the expression of TNF-α and IL-6. In conclusion, current study results indicate that organic OG can positively affect the OPG/RANKL ratio and inhibit the expression of serum inflammatory cytokines; thus, it can improve osteoporotic fracture healing.
Similar content being viewed by others
References
Marcus R (1996) Clinical review 76: the nature of osteoporosis. J Clin Endocrinol Metab 81:1–5
Cimaz R, Biggioggero M (2001) Osteoporosis. Curr Rheumatol Rep 3:365–370
Frost HM, Jee WS (1992) On the rat model of human osteopenias and osteoporoses. Bone and mineral 18:227–236
Lau EM, Cooper C (1996) The epidemiology of osteoporosis. The oriental perspective in a world context. Clinical orthopaedics and related research 65–74
Beattie K, Adachi J, Ioannidis G, Papaioannou A, Leslie WD, Grewal R, MacDermid J, Hodsman AB (2015) Estimating osteoporotic fracture risk following a wrist fracture: a tale of two systems. Arch Osteoporos 10:13
Vitali C, Gussoni G, Bianchi G et al (2015) High prevalence of fragility vertebral fractures in patients hospitalised in Internal Medicine Units. Results of the POINT (Prevalence of Osteoporosis in INTernal medicine) study. Bone 74:114–120
Bliuc D, Center JR (2016) Determinants of mortality risk following osteoporotic fractures. Curr Opin Rheumatol 28:413–419
Namkung-Matthai H, Appleyard R, Jansen J, Hao Lin J, Maastricht S, Swain M, Mason RS, Murrell GA, Diwan AD, Diamond T (2001) Osteoporosis influences the early period of fracture healing in a rat osteoporotic model. Bone 28:80–86
Thomas-John M, Codd MB, Manne S, Watts NB, Mongey AB (2009) Risk factors for the development of osteoporosis and osteoporotic fractures among older men. J Rheumatol 36:1947–1952
Lee JH, Cho SK, Han M, Lee S, Kim JY, Ryu JA, Choi YY, Bae SC, Sung YK (2014) Validity and role of vertebral fracture assessment in detecting prevalent vertebral fracture in patients with rheumatoid arthritis. Joint, bone, spine : revue du rhumatisme 81:149–153
Murphy CM, Schindeler A, Cantrill LC, Mikulec K, Peacock L, Little DG (2015) PTH(1-34) treatment increases bisphosphonate turnover in fracture repair in rats. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 30:1022–1029
Boytsov N, Zhang X, Sugihara T, Taylor K, Swindle R (2015) Osteoporotic fractures and associated hospitalizations among patients treated with teriparatide compared to a matched cohort of patients not treated with teriparatide. Curr Med Res Opin 31:1665–1675
Hao Y, Wang X, Wang L, Lu Y, Mao Z, Ge S, Dai K (2015) Zoledronic acid suppresses callus remodeling but enhances callus strength in an osteoporotic rat model of fracture healing. Bone 81:702–711
Maier GS, Seeger JB, Horas K, Roth KE, Kurth AA, Maus U (2015) The prevalence of vitamin D deficiency in patients with vertebral fragility fractures. Bone Joint J 97-B:89–93
Cauley JA (2015) Estrogen and bone health in men and women. Steroids 99:11–15
Casper ES, Stanton GF, Sordillo PP, Parente R, Michaelson RA, Vinceguerra V (1985) Phase II trial of gallium nitrate in patients with advanced malignant melanoma. Cancer treatment reports 69:1019–1020
Straus DJ (2003) Gallium nitrate in the treatment of lymphoma. Semin Oncol 30:25–33
Collery P, Keppler B, Madoulet C, Desoize B (2002) Gallium in cancer treatment. Crit Rev Oncol Hematol 42:283–296
Donnelly R, Bockman RS, Doty SB, Boskey AL (1991) Bone particles from gallium-treated rats are resistant to resorption in vivo. Bone and mineral 12:167–179
Warrell RP, Jr., Bockman RS (1989) Gallium in the treatment of hypercalcemia and bone metastasis. Important Adv Oncol 205–220
Hughes S, Peel-White AL, Peterson CK (1992) Paget’s disease of bone—current thinking and management. J Manip Physiol Ther 15:242–249
Warrell RP Jr, Bosco B, Weinerman S, Levine B, Lane J, Bockman RS (1990) Gallium nitrate for advanced Paget disease of bone: effectiveness and dose-response analysis. Ann Intern Med 113:847–851
Chitambar CR (2010) Medical applications and toxicities of gallium compounds. Int J Environ Res Public Health 7:2337–2361
Bernstein LR, Tanner T, Godfrey C, Noll B (2000) Chemistry and pharmacokinetics of gallium maltolate, a compound with high oral gallium bioavailability. Metal-Based Drugs 7:33–47
Han C, Yuan J, Wang Y, Li L (2006) Hypoglycemic activity of fermented mushroom of Coprinus comatus rich in vanadium. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements 20:191–196
Ma Z, Fu Q (2010) Therapeutic effect of organic gallium on ovariectomized osteopenic rats by decreased serum minerals and increased bone mineral content. Biol Trace Elem Res 133:342–349
Ma Z, Fu Q (2010) Comparison of the therapeutic effects of yeast-incorporated gallium with those of inorganic gallium on ovariectomized osteopenic rats. Biol Trace Elem Res 134:280–287
Pei Y, Fu Q (2011) Yeast-incorporated gallium promotes fracture healing by increasing callus bony area and improving trabecular microstructure on ovariectomized osteopenic rats. Biol Trace Elem Res 141:207–215
Kalu DN (1991) The ovariectomized rat model of postmenopausal bone loss. Bone and mineral 15:175–191
Stenstrom M, Olander B, Carlsson CA, Carlsson GA, Lehto-Axtelius D, Hakanson R (1998) The use of computed microtomography to monitor morphological changes in small animals. Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine 49:565–570
Lehnerdt G, Unkel C, Metz KA, Jahnke K, Neumann A (2008) Immunohistochemical evidence of BMP-2, -4 and -7 activity in otospongiosis. Acta Otolaryngol 128:13–17
Shanmugarajan S, Tsuruga E, Swoboda KJ, Maria BL, Ries WL, Reddy SV (2009) Bone loss in survival motor neuron (Smn(−/−) SMN2) genetic mouse model of spinal muscular atrophy. J Pathol 219:52–60
Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods 25:402–408
Lacey DL, Timms E, Tan HL et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93:165–176
Filvaroff E, Derynck R (1998) Bone remodelling: a signalling system for osteoclast regulation. Current biology : CB 8:R679–R682
Kanis JA (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 4:368–381
Verron E, Masson M, Khoshniat S et al (2010) Gallium modulates osteoclastic bone resorption in vitro without affecting osteoblasts. Br J Pharmacol 159:1681–1692
Maquer G, Musy SN, Wandel J, Gross T, Zysset PK (2015) Bone volume fraction and fabric anisotropy are better determinants of trabecular bone stiffness than other morphological variables. J Bone Miner Res: Official J Am Soc Bone Miner Res 30:1000–1008
Rath C, Baum T, Monetti R et al (2013) Scaling relations between trabecular bone volume fraction and microstructure at different skeletal sites. Bone 57:377–383
Wozney JM (1989) Bone morphogenetic proteins. Prog Growth Factor Res 1:267–280
Hall TJ, Chambers TJ (1990) Gallium inhibits bone resorption by a direct effect on osteoclasts. Bone Miner 8:211–216
Verron E, Loubat A, Carle GF, Vignes-Colombeix C, Strazic I, Guicheux J, Rochet N, Bouler JM, Scimeca JC (2012) Molecular effects of gallium on osteoclastic differentiation of mouse and human monocytes. Biochem Pharmacol 83:671–679
Strazic-Geljic I, Guberovic I, Didak B, Schmid-Antomarchi H, Schmid-Alliana A, Boukhechba F, Bouler JM, Scimeca JC, Verron E (2016) Gallium, a promising candidate to disrupt the vicious cycle driving osteolytic metastases. Biochem Pharmacol 116:11–21
Stern LS, Matkovic V, Weisbrode SE, Apseloff G, Shepard DR, Mays DC, Gerber N (1994) The effects of gallium nitrate on osteopenia induced by ovariectomy and a low-calcium diet in rats. Bone and mineral 25:59–69
Jenis LG, Waud CE, Stein GS, Lian JB, Baran DT (1993) Effect of gallium nitrate in vitro and in normal rats. J Cell Biochem 52:330–336
Udagawa N (2002) Mechanisms involved in bone resorption. Biogerontology 3:79–83
Udagawa N, Takahashi N, Yasuda H et al (2000) Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function. Endocrinology 141:3478–3484
Aubin JE, Bonnelye E (2000) Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 11:905–913
Hofbauer LC, Kuhne CA, Viereck V (2004) The OPG/RANKL/RANK system in metabolic bone diseases. J Musculoskelet Neuronal Interact 4:268–275
Takayanagi H (2005) Mechanistic insight into osteoclast differentiation in osteoimmunology. J Mol Med 83:170–179
Wong PK, Quinn JM, Sims NA, van Nieuwenhuijze A, Campbell IK, Wicks IP (2006) Interleukin-6 modulates production of T lymphocyte-derived cytokines in antigen-induced arthritis and drives inflammation-induced osteoclastogenesis. Arthritis Rheum 54:158–168
Inanir A, Ozoran K, Tutkak H, Mermerci B (2004) The effects of calcitriol therapy on serum interleukin-1, interleukin-6 and tumour necrosis factor-alpha concentrations in post-menopausal patients with osteoporosis. J Int Med Res 32:570–582
Kwan Tat S, Padrines M, Theoleyre S, Heymann D, Fortun Y (2004) IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev 15:49–60
Choi JH, Lee JH, Roh KH et al (2014) Gallium nitrate ameliorates type II collagen-induced arthritis in mice. Int Immunopharmacol 20:269–275
Makkonen N, Hirvonen MR, Savolainen K, Lapinjoki S, Monkkonen J (1995) The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro. Inflamm Res 44:523–528
Merryman JI, Capen CC, Rosol TJ (1994) Effects of gallium nitrate in nude mice bearing a canine adenocarcinoma (CAC-8) model of humoral hypercalcemia of malignancy. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research 9:725–732
Acknowledgements
This research was funded by the National Natural Science Foundation of China (No. 81070688).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Experimental protocols were reviewed and approved by Chinese Legislation for animal usage.
Rights and permissions
About this article
Cite this article
Wang, J., He, M., Wang, G. et al. Organic Gallium Treatment Improves Osteoporotic Fracture Healing Through Affecting the OPG/RANKL Ratio and Expression of Serum Inflammatory Cytokines in Ovariectomized Rats. Biol Trace Elem Res 183, 270–279 (2018). https://doi.org/10.1007/s12011-017-1123-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-017-1123-y